Giordano de Guglielmo Selected Research

Giordano de Guglielmo Research Topics

Disease

9	Alcoholism (Alcohol Abuse) 01/2021 - 11/2009
7	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 12/2014
6	Substance-Related Disorders (Drug Abuse) 01/2022 - 12/2014
6	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 03/2013
5	Hyperalgesia 10/2020 - 05/2018
3	Inflammation (Inflammations) 01/2022 - 01/2019
3	Body Weight (Weight, Body) 01/2020 - 01/2017
2	Food Addiction 01/2022 - 01/2020
2	Heroin Dependence (Heroin Abuse) 01/2018 - 08/2017
2	Partial Epilepsies (Epilepsy, Partial) 07/2013 - 03/2012
2	Neuralgia (Stump Neuralgia) 07/2013 - 03/2012
2	Anxiety Disorders (Anxiety Disorder) 07/2013 - 03/2012
1	Feeding and Eating Disorders (Eating Disorder) 01/2022
1	Cognitive Dysfunction 01/2022
1	Drug Overdose 01/2022
1	Obesity 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Prescription Drug Misuse 01/2022
1	Pain (Aches) 05/2020
1	Disease Progression 01/2020
1	Chronic Pain 01/2020
1	Tobacco Use Disorder (Nicotine Dependence) 11/2019
1	Hyperuricemia 01/2019
1	Gout 01/2019
1	Weight Gain 01/2018
1	Mental Disorders (Mental Disorder) 01/2017
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2017
1	Acute Pain 01/2017
1	Type 2 Diabetes Mellitus (MODY) 08/2013
1	Insulin Resistance 08/2013

Drug/Important Bio-Agent (IBA)

8	Opioid Analgesics (Opioids)IBA 01/2022 - 12/2014
4	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022 - 01/2019
4	Nicotine FDA Link 10/2020 - 04/2015
4	NociceptinIBA 01/2017 - 11/2009
3	Cocaine (Cocaine HCl)IBA 01/2022 - 01/2018
3	Analgesics (Analgesic Drugs)IBA 01/2019 - 12/2014
2	LeptinIBA 01/2022 - 01/2020
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2015
2	Pioglitazone (Actos)FDA Link 01/2017 - 08/2013
2	Peptides (Polypeptides)IBA 01/2017 - 07/2015
2	Aminobutyrates (Aminobutyric Acid)IBA 07/2013 - 03/2012
2	Pregabalin (Lyrica)FDA Link 07/2013 - 03/2012
2	gamma-Aminobutyric Acid (GABA)IBA 07/2013 - 03/2012
1	GlucocorticoidsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	paraform (paraformaldehyde)IBA 05/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	Organic Anion TransportersIBA 01/2019
1	Probenecid (Benemid)FDA LinkGeneric 01/2019
1	Benzoic Acid (Potassium Benzoate)FDA Link 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	VK4-116IBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2018
1	CannabinoidsIBA 01/2018
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2018
1	A-factor (Streptomyces)IBA 01/2018
1	Heroin (Diamorphine)IBA 08/2017
1	Therapeutic UsesIBA 08/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 01/2017
1	Corticotropin-Releasing HormoneIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Morphine (MS Contin)FDA LinkGeneric 01/2017
1	Naloxone (Narcan)FDA LinkGeneric 01/2017
1	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Calcium Channels (Calcium Channel)IBA 01/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2013
1	Naltrexone (ReVia)FDA LinkGeneric 08/2013
1	ElementsIBA 03/2013
1	Nociceptin ReceptorIBA 11/2009
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2009
1	NeuropeptidesIBA 11/2009

Therapy/Procedure

9	Self Administration (Administration, Self) 01/2022 - 07/2017
3	Therapeutics 01/2022 - 08/2017
1	Pain Management 01/2019
1	Deep Brain Stimulation 08/2017
1	Secondary Prevention 07/2015